Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending August 1, 2003. The report details a specific corporate action regarding share re-purchases executed in accordance with shareholder authority granted at the Annual General Meeting on May 19, 2003.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial data disclosed relates to the share re-purchase transaction:
- Shares Purchased: 1,320,000 ordinary shares
- Purchase Date: July 31, 2003
- Price Per Share: 1,190.15p
- Transaction Purpose: Cancellation of shares
Material Changes
The filing does not disclose material changes in financial performance or operations compared to prior periods. The primary change reported is the reduction of the company's share capital through the cancellation of 1,320,000 shares.
Guidance, Outlook, and Risks
The filing contains no management commentary, future guidance, outlook, risk factors, or contingencies. It is a notification of a completed transaction.
Investor Verification Points
- Verify the total cost of the re-purchase (1,320,000 shares at 1,190.15p per share).
- Confirm the remaining authorized share buyback limit following this transaction.
- Check subsequent filings for the impact of share cancellation on earnings per share (EPS).